Preclinical Showcase of XmAb541 in Claudin 6-Targeted Bispecific Antibody Therapy
Time: 9:30 am
day: Conference Day 1
Details:
- Showcasing Xencor’s XmAb541, a CLDN6 x CD3 bispecific antibody, designed to engage T cells and selectively kill claudin 6 expressing tumor cells while sparing normal tissues
